Shandong University: Communicable Diseases trials

The registry lists 11 Communicable Diseases studies with Shandong University as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 4 4No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal InfectionsRecruitingNCT06711575
• Population Pharmacokinetics, Effectiveness and Safety of Cefuroxime in NeonatesRecruitingNCT05388747
• Antibiotic Therapy for Infectious DiseasesRecruitingNCT04937894
• Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese FemaleRecruitingNCT04633330Not applicable
• The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori InfectionStatus unknownNCT05620589
• 14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori InfectionStatus unknownNCT05438550Phase 4
• Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori InfectionStatus unknownNCT05133193Not applicable
• Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong ProvinceCompletedNCT04918134
• Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori InfectionCompletedNCT03658746Phase 4
• A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori InfectionStatus unknownNCT03658733Phase 4
• Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori InfectionStatus unknownNCT03616405Phase 4